Differentially expressed genes (DEGs) involved in the onset of T2DM in insulin-sensitive and insulin-producing tissues from anti-diabetic drug-treated animals have been reported to understand the molecular mechanisms involved in T2DM pathogenesis [4], [6], [14], [16]. This evidence concerns the gene INS and type 2 diabetes mellitus.